J. Weng, A. Huang, T. B. Berake, S. L. Chen, B. M. Yan, and R. Karagozian, “Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease”, Gastroenterol Res, vol. 19, no. 3, pp. 147–154, Jan. 2026, doi: 10.14740/gr2136.